Breaking News Instant updates and real-time market news.

AMZN

Amazon.com

$987.71

23.54 (2.44%)

, WFM

Bought by AMZN

$42.68

9.62 (29.10%)

12:42
06/18/17
06/18
12:42
06/18/17
12:42

Amazon deal for Whole Foods has 'staggering' implications, Barron's says

Amazon's (AMZN) proposed acquisition of Whole Foods (WFM) has "staggering" implications for grocers, Barron's contends in a feature article. Shares of Wal-Mart (WMT), Target (TGT), Kroger (KR), Costco (COST) and Walgreens (WBA) fell after news of the acquisition, and Barron's argues that investors are concerned about Amazon's ability to leverage Whole Foods with its AmazonFresh online grocery business and its technology. The acquisition "looks particularly bearish" for Kroger, the publication says. A bidding war for Whole Foods could erupt and, while Amazon has enough money to "win any battle," Wal-Mart has plenty of cash, and Kroger and Albertsons could also lob offers. As for traders looking to take advantage of the retail selloff, Barron's argues that Costco "looks appealing." Reference Link

AMZN

Amazon.com

$987.71

23.54 (2.44%)

WFM

Bought by AMZN

$42.68

9.62 (29.10%)

WMT

Walmart

$75.24

-3.67 (-4.65%)

TGT

Target

$52.61

-2.85 (-5.14%)

KR

Kroger

$22.29

-2.27 (-9.24%)

COST

Costco

$167.11

-12.95 (-7.19%)

WBA

Walgreens Boots Alliance

$78.44

-4.12 (-4.99%)

  • 20

    Jun

  • 22

    Jun

  • 29

    Jun

  • 23

    Aug

AMZN Amazon.com
$987.71

23.54 (2.44%)

06/16/17
PIPR
06/16/17
NO CHANGE
Target $1200
PIPR
Overweight
Piper reiterates $1,200 target on Amazon following Whole Foods deal
Piper Jaffray analyst Michael Olson believes the importance of Amazon's (AMZN) acquisition of Whole Foods (WFM) centers on the accelerations in its grocery strategy. Amazon's proximity to the U.S. consumer with grocery delivery range locations will increase from 20%-30% to near ubiquity, which "significantly" accelerates its grocery go-to-market, Olson tells investors in a research note titled "The Future of Grocery is Bright, Disruptive and Amazon's." Further, he believes Whole Foods' localized sourcing can "significantly improve" Amazon's grocery SKU quality. He reiterates an Overweight rating on Amazon with a $1,200 price target.
06/16/17
JEFF
06/16/17
NO CHANGE
Target $88
JEFF
Buy
Wal-Mart should be rallying on Whole Foods takeover, says Jefferies
Jefferies analyst Daniel Binder views the "knee-jerk" selloff in Wal-Mart (WMT) shares following Amazon's (AMZN) acquisition of Whole Foods (WFM) as overdone. The deal suggests having a store base in food "is important after all," Binder tells investors in a research note. Investors should be buying Wal-Mart today, not "taking it to the woodshed," the analyst argues. The company has roughly 4,500 points of distribution in food while Amazon just bought 461, Binder writes in a research note titled "Stores Are Important After All!." He recommends buying Wal-Mart on the weakness today and keeps a Buy rating on the name with an $88 price target. The retailing giant is down 5%, or $3.67, to $75.24 in afternoon trading.
06/16/17
BARD
06/16/17
NO CHANGE
BARD
Wal-Mart, Costco weakness on Amazon news a buying opportunity, says Baird
Baird analyst Peter Benedict said he we views Amazon's (AMZN) deal to buy Whole Foods (WFM) as reinforcing the value of local distribution and he believes Wal-Mart (WMT) and Costco (COST) are particularly well positioned to compete in the omni-channel grocery market. The analyst, who recommends using today's weakness in those two stocks as a buying opportunity, keeps an Outperform rating on both, while maintaining a Neutral rating on Target (TGT), noting that he thinks today's news "raises the bar" on its need to find an effective strategy to turn its grocery business.
06/16/17
06/16/17
DOWNGRADE

Neutral
Costco downgraded to Neutral from Conviction Buy at Goldman Sachs
As previously reported, Goldman downgraded Costco (COST) to Neutral from Conviction Buy and lowered its price target to $176 from $197. Analyst Matthew Fassler believes Costco's valuation will be capped due to Amazon's (AMZN) ongoing moves into consumables, online investments by Wal-Mart (WMT) and fading fundamental catalysts. He believes Amazon will offer superior pricing and delivery competency versus incumbents but does not anticipate meaningful erosion in warehouse business trends any time soon.
WFM Bought by AMZN
$42.68

9.62 (29.10%)

06/16/17
LEHM
06/16/17
UPGRADE
Target $48
LEHM
Overweight
Barclays upgrades Whole Foods on potential for bidding war
As previously reported, Barclays analyst Karen Short upgraded Whole Foods (WFM) to Overweight from Equal Weight and raised her price target on the stock to $48 from $38, telling investors that she would not be surprised to see a bidding war break out following Amazon's (AMZN) announcement of a takeover agreement. Short, who thinks a strategic retail buyer would generate up to $600M in synergies from a deal to buy Whole Foods, said bidders could include Kroger (KR), Target (TGT), and Wal-Mart (WMT), all of which may "have too much to lose not to bid."
WMT Walmart
$75.24

-3.67 (-4.65%)

06/16/17
06/16/17
NO CHANGE

Pacific Crest calls Amazon deal a 'turning point' in fight with Wal-Mart
Amazon's (AMZN) agreement to acquire Whole Foods (WFM) marks a "significant step" in its push into physical retail and a "turning point" in the company's battle against Wal-Mart (WMT), Pacific Crest analyst Edward Yruma tells investors in an intraday research note. The deal gives Amazon attractively located stores, a very strong brand, and "credibility" within food retail, added Yruma.
TGT Target
$52.61

-2.85 (-5.14%)

05/09/17
CLVD
05/09/17
NO CHANGE
CLVD
Neutral
Target Q1 comps likely ahead, but outlook remains cautious, says Cleveland
Cleveland Research analyst Scott Bender said Target sales appear to have improved in Q1 against easier comps and sees upside to consensus comp expectations for the quarter. However, the channel outlook remains cautious as there are concerns that EDLP could hurt sales, and the merchandising re-organization could cause disruptions. Bender has a Neutral rating on Target.
05/17/17
BARD
05/17/17
NO CHANGE
Target $55
BARD
Neutral
Target Q1 results a positive step, but visibility still low, says Baird
Baird analyst Peter Benedict said Target's Q1 earnings beat was "a step in the right direction," but he adds that the bar was low and visibility remain limited. Week-to-week results remain volatile and driving positive comps remains the key for a re-rating of the stock, contends Benedict, who keeps a Neutral rating and $55 price target on Target shares.
KR Kroger
$22.29

-2.27 (-9.24%)

06/16/17
06/16/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Nike (NKE) downgraded to Neutral from Overweight at JPMorgan with analyst Matthew Boss saying his work suggests Nike's sales in North America are likely to get worse before getting better. 2. Kroger (KR) downgraded to Neutral from Buy at Goldman Sachs, to Neutral from Overweight at JPMorgan, and to Market Perform from Outperform at Telsey Advisory. 3. Booz Allen (BAH) was downgraded to Neutral from Buy at BofA/Merrill, to Hold from Buy at Vertical Research, and to Market Perform from Outperform at Raymond James. 4. Square (SQ) downgraded to Neutral from Outperform at Credit Suisse with analyst Paul Condra saying the shares at current levels are fully valued. 5. Noble Corp. (NE) downgraded to Neutral from Buy at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/16/17
BARD
06/16/17
NO CHANGE
Target $72
BARD
Outperform
Amazon deal for Whole Foods a 'mild negative' for Vantiv, says Baird
Baird analyst David Koning believes Whole Foods (WFM) could be about 0.15-0.2% of Vantiv's (VNTV) revenue, making the deal for the grocer to be acquired by Amazon (AMZN) a "mild negative" for Vantiv. Vantiv may trade down today following that news and the guidance cut from Kroger (KR), which Koning estimates accounts for about 1% of Vantiv's revenue. However, he likes Vantiv shares given its valuation and potential for rising estimates and keeps an Outperform rating and $72 price target on the stock.
06/16/17
RBCM
06/16/17
NO CHANGE
RBCM
Kroger risk/reward 'favorable,' says RBC Capital
After Kroger lowered its fiscal 2017 EPS guidance. RBC Capital analyst William Kirk says that the company's increased investments in prices and labor are "alarming." However, the analyst notes that the company still had positive ID sales so far this quarter, and he thinks that it will benefit from the closure of a number of competing stores. He says that the stock's risk/reward ratio is positive, and he keeps an Outperform rating on the stock.
COST Costco
$167.11

-12.95 (-7.19%)

05/26/17
FBCO
05/26/17
NO CHANGE
Target $195
FBCO
Outperform
Costco price target raised to $195 after 'bounce-back quarter' at Credit Suisse
Credit Suisse analyst Edward Kelly noted that Costco followed up a "disappointing" Q2 performance with a "much better" Q3, noting that its new card continued to contribute while core merchandise margin also improved and fuel turned into a tailwind. The quarterly report was "clearly positive," comparisons remain fairly easy in the near-term and Costco's performance is notable given the landscape of other "structurally challenged retail names," which suggests the stock could still have legs, Kelly tells investors. He raised his price target to $195 from $187 and keeps an Outperform rating on Costco shares.
06/16/17
GSCO
06/16/17
DOWNGRADE
GSCO
Neutral
Costco downgraded to Neutral from Conviction Buy at Goldman Sachs
WBA Walgreens Boots Alliance
$78.44

-4.12 (-4.99%)

05/31/17
JEFF
05/31/17
NO CHANGE
Target $95
JEFF
Buy
Walgreens has upside with or without Rite Aid, says Jefferies
Jefferies analyst Brian Tanquilut believes shares of Walgreens Boots Alliance (WBA) have upside with or without the successful closing of the Rite Aid (RAD) acquisition. If the FTC blocks the deal, Walgreens is likely to put through a "sizeable" repurchase, Tanquilut tells investors in a research note. If the deal is approved, the analyst continues to expect earnings accretion beginning in 2018. The analyst finds it "difficult to handicap the odds" of an FTC approval. Nonetheless, he remains a buyer of Walgreens at current share levels. Tanquilut has a Buy rating on the name with a $95 price target.
05/31/17
COWN
05/31/17
NO CHANGE
Target $5
COWN
Outperform
Cowen believes Walgreens will pursue Rite Aid even if FTC acts to block merger
Cowen analyst Charles Ryhee said the FTC decision on the merger between Walgreens (WBA)and Rite Aid (RAD) is too difficult to call, but he believes although Rite Aid will struggle on its own its value to Walgreens is significant. He also believes the value is well above the deal price range and so expects Walgreens will litigate the decision in an attempt to win an approval. Ryhee reiterated his Outperform rating but lowered his price target to $4.70 from $6.75 on Rite Aid shares.
06/06/17
WELS
06/06/17
NO CHANGE
WELS
Amazon may be the next threat to drug pricing, says Wells Fargo
After CNBC recently reported that Amazon (AMZN) is considering going into the prescription pharmacy business in the U.S., Wells Fargo surveyed nearly 2,900 U.S. adults and found that 54% of those polled said they would use or would probably use "Amazon Pharmacy." While the e-commerce giant has not confirmed its U.S. pharmacy interest, if it did enter the market analyst David Maris believes it could see fast adoption and "usher in a new age of price transparency." Maris also wonders if pharmacy "may be just the beginning" and if Amazon eyes the "even larger prize" of fully integrated digital healthcare. Publicly traded large-cap pharmaceuticals companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded retail pharmacy operators include CVS Health (CVS), Walgreens (WBA), Fred's (FRED) and Rite Aid (RAD).
06/13/17
BARD
06/13/17
NO CHANGE
Target $96
BARD
Outperform
Walgreens Boots Alliance Q3 results will include deal contingencies, says Baird
Baird analyst Eric Coldwell noted Walgreens Boots Alliance (WBA) will report Q3 results on June 29 and its focus will be on ramping wins in the U.S. and the start of Alliance Rx. He also believes there will be an update on the Rite Aid (RAD) deal and although he would prefer the deal to close, he is prepared for contingency plans, which may include a stock buyback. Coldwell maintained his Outperform rating and $96 price target on Walgreens shares.

TODAY'S FREE FLY STORIES

CPB

Campbell Soup

$45.51

-0.24 (-0.52%)

06:37
01/16/18
01/16
06:37
01/16/18
06:37
Upgrade
Campbell Soup rating change  »

Campbell Soup upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDX

Market Vector Gold Miners

$24.01

0.63 (2.69%)

06:36
01/16/18
01/16
06:36
01/16/18
06:36
Technical Analysis
Market Vector Gold Miners: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$126.96

1.52 (1.21%)

06:35
01/16/18
01/16
06:35
01/16/18
06:35
Technical Analysis
SPDR Gold Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$27.53

0.38 (1.40%)

06:34
01/16/18
01/16
06:34
01/16/18
06:34
Periodicals
Airbus prepared to shut down production of A380 superjumbo, FT reports »

Airbus is ready to shut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUGT

Direxion Gold Miners Bull

$34.63

2.54 (7.92%)

06:34
01/16/18
01/16
06:34
01/16/18
06:34
Technical Analysis
Direxion Gold Miners Bull: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$18.81

1.47 (8.48%)

06:33
01/16/18
01/16
06:33
01/16/18
06:33
Technical Analysis
Direxion Daily Jr Gld Mnrs Bull 3X Shrs: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOXA

21st Century Fox

$36.73

0.53 (1.46%)

06:32
01/16/18
01/16
06:32
01/16/18
06:32
Upgrade
21st Century Fox rating change  »

21st Century Fox upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

DUST

Direxion Daily Gold Miners Bear 3X ETF

$21.30

-1.89 (-8.15%)

06:32
01/16/18
01/16
06:32
01/16/18
06:32
Technical Analysis
Direxion Daily Gold Miners Bear 3X ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SP

SP Plus Corp.

$38.00

0.2 (0.53%)

06:31
01/16/18
01/16
06:31
01/16/18
06:31
Hot Stocks
SP Plus Corp. sells joint venture interest in Parkmobile, sees Q1 gain »

SP Plus Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$47.10

-4.42 (-8.58%)

06:31
01/16/18
01/16
06:31
01/16/18
06:31
Technical Analysis
Direxion Daily Junior Gold Miners Index Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VXX

iPath S&P 500 VIX Short-Term Futures

$25.85

0.01 (0.04%)

06:30
01/16/18
01/16
06:30
01/16/18
06:30
Technical Analysis
iPath S&P 500 VIX Short-Term Futures: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLB

Dolby

$65.35

1.06 (1.65%)

06:29
01/16/18
01/16
06:29
01/16/18
06:29
Downgrade
Dolby rating change  »

Dolby downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XIV

VelocityShares Daily Inverse VIX Short-Term ETN

$144.75

-0.25 (-0.17%)

06:29
01/16/18
01/16
06:29
01/16/18
06:29
Technical Analysis
VelocityShares Daily Inverse VIX Short-Term ETN: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$76.84

1.28 (1.69%)

06:28
01/16/18
01/16
06:28
01/16/18
06:28
Periodicals
Citi results likely 'overwhelmed' by $20B charge due to tax overhaul, WSJ says »

Citigroup's results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 24

    Jan

JPM

JPMorgan

$112.67

1.83 (1.65%)

06:28
01/16/18
01/16
06:28
01/16/18
06:28
Hot Stocks
JPMorgan reports December net credit losses 2.43% vs. 2.36% last month »

Reports December 30-plus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

TVIX

VelocityShares Daily 2x VIX Short-Term ETN

$4.74

0.01 (0.21%)

06:27
01/16/18
01/16
06:27
01/16/18
06:27
Technical Analysis
VelocityShares Daily 2x VIX Short-Term ETN: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INNV

Innovus Pharmaceuticals

06:27
01/16/18
01/16
06:27
01/16/18
06:27
Hot Stocks
Innovus Pharmaceuticals' hemorrhoid drug Xyralid approved in Canada »

Innovus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVXY

ProShares Short VIX Short-Term Futures

$138.19

-0.02 (-0.01%)

06:26
01/16/18
01/16
06:26
01/16/18
06:26
Technical Analysis
ProShares Short VIX Short-Term Futures: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TYL

Tyler Technologies

$187.95

0.06 (0.03%)

06:25
01/16/18
01/16
06:25
01/16/18
06:25
Recommendations
Tyler Technologies analyst commentary  »

Tyler Technologies price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 26

    Feb

FCAU

Fiat Chrysler

$23.39

-0.03 (-0.13%)

06:25
01/16/18
01/16
06:25
01/16/18
06:25
Periodicals
Fiat Chrysler's Marchionne says new CEO to be named this year, AP reports »

Fiat Chrysler CEO Sergio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$221.23

3.99 (1.84%)

, NTDOY

Nintendo

$50.40

0.69 (1.39%)

06:25
01/16/18
01/16
06:25
01/16/18
06:25
Periodicals
Netflix 'exploring' possibility of launching on Nintendo Switch, Polygon says »

In a statement sent to…

NFLX

Netflix

$221.23

3.99 (1.84%)

NTDOY

Nintendo

$50.40

0.69 (1.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 22

    Jan

USO

United States Oil Fund

$12.87

0.17 (1.34%)

06:24
01/16/18
01/16
06:24
01/16/18
06:24
Technical Analysis
United States Oil Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOP

SPDR Oil Exploration and Production Fund

$39.72

0.32 (0.81%)

06:23
01/16/18
01/16
06:23
01/16/18
06:23
Technical Analysis
SPDR Oil Exploration and Production Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOW

ServiceNow

$138.19

0.61 (0.44%)

06:23
01/16/18
01/16
06:23
01/16/18
06:23
Recommendations
ServiceNow analyst commentary  »

ServiceNow price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

BBY

Best Buy

$73.25

1.54 (2.15%)

, WMT

Walmart

$100.87

0.85 (0.85%)

06:23
01/16/18
01/16
06:23
01/16/18
06:23
Recommendations
Best Buy, Walmart, Sears analyst commentary  »

Best Buy price target…

BBY

Best Buy

$73.25

1.54 (2.15%)

WMT

Walmart

$100.87

0.85 (0.85%)

SHLD

Sears

$3.60

0.28 (8.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.